vorinostat has been researched along with Leukemia, Pre-B-Cell in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, C | 2 |
Hogarth, LA | 2 |
Mackenzie, KL | 2 |
Hall, AG | 2 |
Lock, RB | 2 |
Suzuki, K | 1 |
Okuno, Y | 1 |
Kawashima, N | 1 |
Muramatsu, H | 1 |
Okuno, T | 1 |
Wang, X | 1 |
Kataoka, S | 1 |
Sekiya, Y | 1 |
Hamada, M | 1 |
Murakami, N | 1 |
Kojima, D | 1 |
Narita, K | 1 |
Narita, A | 1 |
Sakaguchi, H | 1 |
Sakaguchi, K | 1 |
Yoshida, N | 1 |
Nishio, N | 1 |
Hama, A | 1 |
Takahashi, Y | 1 |
Kudo, K | 1 |
Kato, K | 1 |
Kojima, S | 1 |
Dietrich, PA | 1 |
Bachmann, PS | 1 |
3 other studies available for vorinostat and Leukemia, Pre-B-Cell
Article | Year |
---|---|
p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Caspase 3; Caspase 7; Cell Cycle Checkp | 2015 |
MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
Topics: Adolescent; Bortezomib; Cell Line, Tumor; Child; Dexamethasone; Drug Screening Assays, Antitumor; HE | 2016 |
p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Topics: Acetylation; Adolescent; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Child; Child, Presch | 2011 |